Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Februar 2026

Genmab — Februar 2026

Planlagt Fastgjort Låst Flyttet Genmab
385 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • M Offline
    M Offline
    mortendrost1
    wrote on sidst redigeret af
    #195

    1850 vil stoppe faldet skulle der stå 🙂

    1 Reply Last reply
    0
    • StockBullS Offline
      StockBullS Offline
      StockBull
      wrote on sidst redigeret af
      #196

      Ja enig 🙂

      1 Reply Last reply
      0
      • concilladoC Offline
        concilladoC Offline
        concillado
        wrote on sidst redigeret af
        #197

        Det lader til at Danske Bank begynder at tilbagekøbe for GEN nu ;-).... kurs 1850

        1 Reply Last reply
        0
        • M Offline
          M Offline
          mortendrost1
          wrote on sidst redigeret af
          #198

          Såh luner det lidt igen. lad os se om den modreaktion vare ved 🙂

          1 Reply Last reply
          0
          • concilladoC Offline
            concilladoC Offline
            concillado
            wrote on sidst redigeret af
            #199

            Yup, tilbagekøb i et lidt surt marked er lidt som at tisse i bukserne 😄

            1 Reply Last reply
            0
            • G Offline
              G Offline
              gentogen
              wrote on sidst redigeret af
              #200

              A Study of GEN1106 in Participants With Solid Tumors.This is a first-in-human (FIH), open-label, multicenter, dose escalation and expansion trial in participants with urothelial and other cancers who have metastatic disease.https://clinicaltrials.gov/study/NCT07416123?term=genmab&aggFilters=status:not&rank=2

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #201

                William Blair analyst Matt Phipps has reiterated their bullish stance on GMAB stock, giving a Buy rating today. https://www.tipranks.com/news/ratings/genmab-near-term-guidance-miss-offset-by-strong-results-and-blockbuster-late-stage-pipeline-upside-ratings-news

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #202

                  Goldman Sachs has lowered its price target for Genmab to 1,771 Danish kroner (previously 1,793), while reiterating its neutral rating

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    ProinvestorNEWS
                    wrote on sidst redigeret af
                    #203

                    Genmab/AL Sydbank: Investorerne fælder hård dom - fokus bør være på pipelinen https://proinvestor.com/investornyt/1413609/genmab-al-sydbank-investorerne-faelder-hard-dom-fokus-bor-vaere-pa-pipelinen

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #204

                      H.C. Wainwright raised the firm's price target on Genmab to $40 from $39 and keeps a Buy rating

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #205

                        if i would have to guess, i would say that is the ADC @gentogen , GEN1107
                        was a Profound Bio ADC ?

                        1 Reply Last reply
                        0
                        • G Offline
                          G Offline
                          gentogen
                          wrote on sidst redigeret af
                          #206

                          sounds reasonable

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #207

                            Genmab fik 79 mio. kr. i betaling fra Novo Nordisk i 2025
                            Genmab fik samlet set 97 mio. dollar – svarende til over 613 mio. kr. – i milepælsbetalinger fra selskabets partnere i 2025. https://medwatch.dk/brancher/Medicinal___Biotek/article19028155.ece

                            1 Reply Last reply
                            0
                            • G Offline
                              G Offline
                              gentogen
                              wrote on sidst redigeret af
                              #208

                              Ja, Og godt 4,1 milliarder kroner i royalties fra andet end dara

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #209

                                Charlie Haywood from Bank of America Securities maintained a Buy rating on Genmab A/S, with a price target of DKK2,500

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #210

                                  RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer https://www.jnj.com/media-center/press-releases/rybrevant-faspro-amivantamab-and-hyaluronidase-lpuj-receives-u-s-fda-breakthrough-therapy-designation-for-patients-with-advanced-head-and-neck-cancer

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    Pensionisten
                                    wrote on sidst redigeret af
                                    #211

                                    Hvad sker der dog med Genmab? Eneste aktie i porteføljen idag - men den tager i den grad for sig. Hvad er det, der er så galt med Genmab. Kan i forklare det på godt gammeltdags Dansk.
                                    . Jeg fatter det ikke ?

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      Pensionisten
                                      wrote on sidst redigeret af
                                      #212

                                      rettelse: eneste aktie i rødt i porteføljen idag....

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #213

                                        on the AGM agenda : Re item 7 (b) on the agenda: The Board of Directors proposes to reduce the Company’s share capital by nominally DKK 1,900,000 by cancellation of 1,900,000 of the Company’s holding of shares

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          ProinvestorNEWS
                                          wrote on sidst redigeret af
                                          #214

                                          Investorerne køber og sælger aktier hyppigere. De holder på deres aktier i meget kortere tid end man gjorde i "gamle dage". Men hvordan påvirket det markedet? Hansen og Larsen kommer også omkring en mulig AI-disruption i transportsektoren, som har sendt DSV ud i et markant kursfald. Kan de store speditører modstå presset? (00:45 Genmab) https://proinvestor.com/boards/131192

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper